(Q45657243)

14 December 2017

Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases (English)

1 reference

14 December 2017

United States of America

1 reference

L Clark Paramore

1

1 reference

14 December 2017

Vincent Ciuryla

series ordinal

2

1 reference

14 December 2017

Gabrielle Ciesla

series ordinal

3

1 reference

14 December 2017

Larry Liu

series ordinal

4

1 reference

14 December 2017

1 January 2004

1 reference

14 December 2017

1 reference

14 December 2017

22

1 reference

14 December 2017

275-284

1 reference

14 December 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200422050-00001

14 December 2017

0 references

cites work

Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality

1 reference

12 December 2020

Respiratory syncytial virus and parainfluenza virus

1 reference

12 December 2020

Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn

1 reference

12 December 2020

Respiratory syncytial virus vaccines for otitis media

1 reference

12 December 2020

Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link

1 reference

12 December 2020

Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction

1 reference

12 December 2020

Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis

1 reference

12 December 2020

Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma

1 reference

12 December 2020

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

12 December 2020

Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection

1 reference

12 December 2020

Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

1 reference

12 December 2020

Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.

1 reference

12 December 2020

Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study

1 reference

12 December 2020

The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations

1 reference

12 December 2020

Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age

1 reference

12 December 2020

Hospitalization costs of respiratory syncytial virus infection

1 reference

12 December 2020

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden

1 reference

12 December 2020

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

1 reference

12 December 2020

Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis

1 reference

12 December 2020

The role of respiratory viruses in otitis media

1 reference

12 December 2020

10.2165/00019053-200422050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

14 December 2017

0 references

1 reference